Eagle Pharmaceuticals Income from Continuous Operations 2013-2023 | EGRX
Eagle Pharmaceuticals income from continuous operations from 2013 to 2023. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change